Frankenfield Christopher James (CIK 0001988344)

Latest company ownership

Shares held
300,000
Last filed at
Nov 25, 2025
Confidence Score
49.6
2025Q4
Confidence Score History
2025Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jan 1, 2025 Jan 3, 2025 Xilio Therapeutics, Inc. CFO Sell 15.0 -6,954 -35.89% ✓ $6.8K